Expansion and Diversification of MFS Transporters in .

Front Microbiol

School of Microbiology, Centre for Synthetic Biology and Biotechnology, Environmental Research Institute, APC Microbiome Institute, University College Cork, Cork, Ireland.

Published: January 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In yeasts, proteins of the Major Superfamily Transporter selectively bind and allow the uptake of sugars to permit growth on varied substrates. The genome of brewer's yeast, , encodes multiple hexose transporters (Hxt) to transport glucose and other MFS proteins for maltose, galactose, and other monomers. For sugar uptake, the dairy yeast, , uses Rag1p for glucose, Hgt1 for glucose and galactose, and Lac12 for lactose. In the related industrial species , there are four genes encoding Lac12-like proteins but only one of them, Lac12, can transport lactose. In this study, which initiated with efforts to investigate possible functions encoded by the additional genes in , a genome-wide survey of putative MFS sugar transporters was performed. Unexpectedly, it was found that the and the genes are present as tandem arrays of five to six copies, with the precise number varying between isolates. Heterologous expression of individual genes in and mutagenesis of single and multiple genes in was performed to establish possible substrates for these transporters. The focus was on the sugar galactose since it was already reported in that this hexose was a substrate for both Lac12 and Hgt1. It emerged that three of the four copies of Lac12, four Hgt-like proteins and one Kht-like protein have some capacity to transport galactose when expressed in and inactivation of all eight genes was required to completely abolish galactose uptake in . Analysis of the amino acid sequence of all known yeast galactose transporters failed to identify common residues that explain the selectivity for galactose. Instead, the capacity to transport galactose has arisen three different times in via polymorphisms in proteins that are probably ancestral glucose transporters. Although, this is analogous to , in which Gal2 is related to glucose transporters, there are not conserved amino acid changes, either with Gal2, or among the galactose transporters. The data highlight how gene duplication and functional diversification has provided with versatile capacity to utilise sugars for growth.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335341PMC
http://dx.doi.org/10.3389/fmicb.2018.03330DOI Listing

Publication Analysis

Top Keywords

galactose
9
transporters
8
capacity transport
8
transport galactose
8
amino acid
8
galactose transporters
8
glucose transporters
8
genes
6
proteins
5
glucose
5

Similar Publications

Role of Systemic Glucocorticoids in Reducing IgA and Galactose-Deficient IgA1 Levels in IgA Nephropathy.

Clin J Am Soc Nephrol

September 2025

Kidney Division, Peking University First Hospital, Peking University Institute of Nephrology; Key Laboratory of Kidney Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, China.

Background: The Therapeutic Effects of Steroids in IgA Nephropathy Global (TESTING) trial demonstrated that glucocorticoid therapy reduced proteinuria and improved kidney outcomes in patients with Immunoglobulin A Nephropathy (IgAN). Galactose-deficient IgA1 (Gd-IgA1) plays a central role in IgAN pathogenesis by promoting immune complex formation. However, the effects of glucocorticoid on pathogenic IgA levels remain unclear.

View Article and Find Full Text PDF

Liver-targeted siRNA delivery via artificial red blood cells to lower LDL-C.

Int J Pharm

September 2025

The Fifth Affiliated Hospital, The Affiliated Panyu Central Hospital, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Gu

Elevated levels of low-density lipoprotein cholesterol (LDL-C) are a key risk factor contributing to the progression of ischemic heart disease. Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) with small interfering RNA (siRNA) provides an alternative therapeutic option for lowering LDL-C levels. However, the poor pharmacokinetic profiles of naked siRNA hinder clinical application.

View Article and Find Full Text PDF

Efficient Production of Mano/Xylo-Oligosaccharides with Excellent Probiotic Activity through Coupling Catalysis.

J Agric Food Chem

September 2025

Department of Chemistry and Chemical Engineering, Engineering Research Center of Forestry Biomass Materials and Bioenergy (Ministry of Education), National Forest and Grass Administration Woody Spices (East China) Engineering Technology Research Center, Beijing Forestry University, Beijing 100083, C

This study develops a catalytic system using pyruvic acid (PYA) and Fe to efficiently coproduce xylo-oligosaccharides (XOS) and (manno-oligosaccharides) MOS from food material ( Lam. fruit.) and its waste peel, respectively.

View Article and Find Full Text PDF

This research emphasized the extraction and separation of polysaccharides derived from Syzygium jambos (L.) Alston (PSJAP-5), as well as analyses of their structural characteristics and immunomodulatory activities. This study initially employed response surface methodology to determine the extraction conditions of polysaccharides.

View Article and Find Full Text PDF